Search results for " vascular"

showing 5 items of 945 documents

Efectos del Sorafenib, un inhibidor tirosina quinasa, en el control del tono vascular.

2018

El carcinoma hepatocelular o hepatocarcinoma (HCC) es uno de los tumores sólidos vasculares más conocidos, representa uno de los mayores problemas de salud en todo el mundo, siendo una de las enfermedades más comunes del hígado (70-85%) y una de las mayores causas de mortalidad relacionadas con el cáncer, siendo la tercera causa más común de muerte por cáncer Varias rutas carcinogénicas se han identificado en el desarrollo y progresión del HCC, proporcionando nuevas dianas moleculares para el tratamiento del HCC. Algunos fármacos que afectan a estas rutas incluyen, entre otros, el receptor del factor de crecimiento endotelial vascular (VEGFR). El sorafenib es un fármaco sistémico aprobado p…

tono vascularinhibidor tirosina quinasaUNESCO::CIENCIAS MÉDICASUNESCO::CIENCIAS DE LA VIDAsorafenib:CIENCIAS MÉDICAS [UNESCO]digestive system diseases:CIENCIAS DE LA VIDA [UNESCO]
researchProduct

Index Balearicum (III). Catàleg comentat de les plantes vasculars descrites de les Illes Balears. Addicions (2008-2016) i correccions

2017

Aquesta compilació inclou actualitzacions nomenclaturals i taxonòmiques per al catàleg de plantes vasculars descrites de les Illes Balears. Aquesta actualització inclou plantes descrites entre 2008 i 2016 a més de correccions per a altres tractades en treballs anteriors.

vascular plants; nomenclature; taxonomy; Balearic IslandsBalearic islandsGeographygovernmentgovernment.political_districtForestryplantes vasculars; nomenclatura; taxonomia; Illes Balearsplantas vasculares; nomenclatura; taxonomía; Islas BalearesCheck ListOrsis
researchProduct

Assessment of Cardiovascular Function in Childhood Leukemia Survivors: The Role of the Right Heart

2022

Childhood acute lymphoblastic leukemia (ALL) survivors who underwent chemotherapy with anthracyclines have an increased cardiovascular risk. The aim of the study was to evaluate left and right cardiac chamber performances and vascular endothelial function in childhood ALL survivors. Fifty-four ALL survivors and 37 healthy controls were enrolled. All patients underwent auxological evaluation, blood pressure measurements, biochemical parameters of endothelial dysfunction, flow-mediated dilatation (FMD) of the brachial artery, mean common carotid intima-media thickness (c-IMT), antero-posterior diameter of the infra-renal abdominal aorta (APAO), and echocardiographic assessment. The ALL subjec…

vascular toxicitycardiac function; childhood; acute lymphoblastic leukemia; vascular toxicityPediatrics Perinatology and Child Healthacute lymphoblastic leukemiacardiac functionchildhoodChildren
researchProduct

Non-HLA Antibodies in Hand Transplant Recipients Are Connected to Multiple Acute Rejection Episodes and Endothelial Activation

2022

The role of anti-HLA antibodies in transplant rejection is well-known but the injury associated with non-HLA antibodies is now widely discussed. The aim of our study was to investigate a role of non-HLA antibodies in hand allografts rejection. The study was performed on six patients after hand transplantation. The control group consisted of: 12 kidney transplant recipients and 12 healthy volunteers. The following non-HLA antibodies were tested: antibody against angiotensin II type 1 receptor (AT1R-Ab), antibody against endothelin-1 type-A-receptor (ETAR-Ab), antibody against protease-activated receptor 1 (PAR-1-Ab) and anti-VEGF-A antibody (VEGF-A-Ab). Chosen proinflammatory cytokines (Il-1…

vascularized composite allotransplantationhand transplantation; non-HLA antibodies; rejection; vasculopathy; vascularized composite allotransplantationRMedicineGeneral Medicinerejectionvasculopathynon-HLA antibodieshand transplantationJournal of Clinical Medicine
researchProduct

Vascularized lymph node transfer for treatment of extremity lymphedema: An overview of current controversies regarding donor sites, recipient sites a…

2018

As lymphatic microsurgery has become more common, vascularized lymph node transfer ascended to the forefront in many centers for the surgical management of advanced stages of lymphedema showing substantial clinical improvement. However, no consensus has been reached among experts regarding many details of the procedures, including patient selection criteria, type of treatment, donor, and recipient sites and postoperative evaluation of the outcome. Here, we will review these issues and provide the current results of this procedure.

vascularized lymph node transfer lymphedema lymphatic microsurgerymedicine.medical_specialtymedicine.medical_treatmentTreatment outcome030230 surgery03 medical and health sciences0302 clinical medicinemedicineHumansLymphedemaLymph nodebusiness.industryGeneral surgeryAdvanced stageExtremitiesGeneral MedicineMicrosurgerymedicine.diseaselymphatic microsurgery; lymphedema; vascularized lymph node transfer; Humans; Lymph Nodes; Lymphedema; Treatment Outcome; ExtremitiesLymphatic systemLymphedemamedicine.anatomical_structureTreatment OutcomeOncology030220 oncology & carcinogenesisSurgeryLymph NodesbusinessJournal of surgical oncology
researchProduct